Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

Researchers develop long-lasting growth hormone

05.09.2007
Researchers at the University of Sheffield have developed a long-acting growth hormone for use in human therapy. The new discovery could mean that children and adults with growth hormone disorders will not have to have injections as often, reducing the need for daily treatments.

Most hormones and cytokines have a short life and therefore require frequent injections as therapy. However, the new technology developed by the multidisciplinary team at Sheffield, means that scientists and clinicians are able to generate effective, long-acting hormones which promote growth over a minimum of ten days, after just one injection.

The research, published in the prestigious journal Nature Medicine, shows that the hormones are able to act for longer because of unique characteristics in the new molecules created in Sheffield.

Hormones normally circulate in blood attached to binding proteins that prevent their clearance from the circulation and prolong their biological action. The new molecules created by the scientists, however, are able to bind to each other in a head-to-tail configuration, doubling their molecular mass in the bloodstream. This delays their absorption and elimination from the blood and therefore generates a hormone that will last for a longer period of time.

... more about:
»Injection »develop »hormone

Professor Richard Ross, from the University´s School of Medicine and Biomedical Sciences, said: "We are very excited by these results and believe this technology will bring significant benefit to patients. Children and adults with growth hormone deficiency have to give themselves daily injections and it is hoped that the new technology will reduce the number of times they have to do this to once every two weeks, or even once a month."

Professor Peter Artymiuk, a structural biologist in the University´s Department of Molecular Biology and Biotechnology, added: "Although we are only in the early stages of the drug development process, and any drugs resulting from this research are several years away from approval, it´s wonderful to see the science translate from the computer screen to what we hope will be real benefits for patients."

Professor Jon Sayers, from the University´s School of Medicine and Biomedical Sciences, commented: "We believe that the technology can also be applied to treat inflammatory diseases such as multiple-sclerosis, cancer and metabolic diseases."

The team of academics are founder shareholders in Asterion Ltd, a Biofusion portfolio company from the University of Sheffield, set up in 2001 to commercially exploit this breakthrough. The company, which has been supported by SUEL Ltd, the White Rose Seedcorn Fund and Biofusion, has a major research collaboration with the French pharmaceutical company Ipsen.

Lindsey Bird | EurekAlert!
Further information:
http://www.shef.ac.uk

Further reports about: Injection develop hormone

More articles from Life Sciences:

nachricht Complementing conventional antibiotics
24.05.2018 | Goethe-Universität Frankfurt am Main

nachricht Building a brain, cell by cell: Researchers make a mini neuron network (of two)
23.05.2018 | Institute of Industrial Science, The University of Tokyo

All articles from Life Sciences >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: Molecular switch will facilitate the development of pioneering electro-optical devices

A research team led by physicists at the Technical University of Munich (TUM) has developed molecular nanoswitches that can be toggled between two structurally different states using an applied voltage. They can serve as the basis for a pioneering class of devices that could replace silicon-based components with organic molecules.

The development of new electronic technologies drives the incessant reduction of functional component sizes. In the context of an international collaborative...

Im Focus: LZH showcases laser material processing of tomorrow at the LASYS 2018

At the LASYS 2018, from June 5th to 7th, the Laser Zentrum Hannover e.V. (LZH) will be showcasing processes for the laser material processing of tomorrow in hall 4 at stand 4E75. With blown bomb shells the LZH will present first results of a research project on civil security.

At this year's LASYS, the LZH will exhibit light-based processes such as cutting, welding, ablation and structuring as well as additive manufacturing for...

Im Focus: Self-illuminating pixels for a new display generation

There are videos on the internet that can make one marvel at technology. For example, a smartphone is casually bent around the arm or a thin-film display is rolled in all directions and with almost every diameter. From the user's point of view, this looks fantastic. From a professional point of view, however, the question arises: Is that already possible?

At Display Week 2018, scientists from the Fraunhofer Institute for Applied Polymer Research IAP will be demonstrating today’s technological possibilities and...

Im Focus: Explanation for puzzling quantum oscillations has been found

So-called quantum many-body scars allow quantum systems to stay out of equilibrium much longer, explaining experiment | Study published in Nature Physics

Recently, researchers from Harvard and MIT succeeded in trapping a record 53 atoms and individually controlling their quantum state, realizing what is called a...

Im Focus: Dozens of binaries from Milky Way's globular clusters could be detectable by LISA

Next-generation gravitational wave detector in space will complement LIGO on Earth

The historic first detection of gravitational waves from colliding black holes far outside our galaxy opened a new window to understanding the universe. A...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

VideoLinks
Industry & Economy
Event News

Save the date: Forum European Neuroscience – 07-11 July 2018 in Berlin, Germany

02.05.2018 | Event News

Invitation to the upcoming "Current Topics in Bioinformatics: Big Data in Genomics and Medicine"

13.04.2018 | Event News

Unique scope of UV LED technologies and applications presented in Berlin: ICULTA-2018

12.04.2018 | Event News

 
Latest News

When corals eat plastics

24.05.2018 | Ecology, The Environment and Conservation

Surgery involving ultrasound energy found to treat high blood pressure

24.05.2018 | Medical Engineering

First chip-scale broadband optical system that can sense molecules in the mid-IR

24.05.2018 | Physics and Astronomy

VideoLinks
Science & Research
Overview of more VideoLinks >>>